Suchergebnisse - "Ma, Jie"

PubPharm (69)

1

Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer

enthalten in: BMC medicine | 2022

von Jia, K. | Chen, Y. | Sun, Y. | +12

ErratumIn: BMC Med. 2023 Sep 29;21(1):369. - PMID 37775728

2

Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer

enthalten in: International journal of radiation oncology, biology, physics | 2022

von Li, L. | Tang, S. | Yin, J. | +20

3

Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes

enthalten in: BMC medical genomics | 2022

von Li, G. | He, R. | Liu, J. | +8

4

Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer

enthalten in: BMC cancer | 2022

von Ran, H. | Ma, J. | Cai, L. | +6

5

Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis

enthalten in: Oxidative medicine and cellular longevity | 2022

von Ma, J. | Chen, X. | Xiang, Z.

6

Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma

enthalten in: Contrast media & molecular imaging | 2022

von Ma, J. | Yao, Y. | Tao, D. | +7

RetractionIn: Contrast Media Mol Imaging. 2023 Jul 19;2023:9783040. - PMID 37502536

7

Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis

enthalten in: BMC cancer | 2021

von Li, R. | Pang, X. | Huang, Z. | +4

8

A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer

enthalten in: Scientific reports | 2021

von Wei, B. | Wu, F. | Xing, W. | +8

9

A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules

enthalten in: BMC cancer | 2021

von Xing, W. | Sun, H. | Yan, C. | +4

10

Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

enthalten in: BMC cancer | 2021

von Zhang, L. | Niu, H. | Yang, P. | +4

1
2
3
4
5
6
7
Nächster »
[7]